LexisNexis® Legal Newsroom
Women on the Verge: Menopause Symptoms in the Workplace

By Robin E. Kobayashi, JD, LexisNexis Legal & Professional Operations When it comes to employee wellness and costs borne by employers, studies tend to focus on the “big three”: cardiovascular disease, cancer, and diabetes. But no one—well, at least in our workers’ comp...

Price Controls on Specialty Pharmaceuticals: Global Perspectives on the Free Market Debate

Karen C. Yotis, Esq., a Feature Resident Columnist for the LexisNexis Workers’ Compensation eNewsletter , provides insights into workplace issues and the nuts and bolts of the workers’ comp world. We love our pharmaceuticals here in the U S of A and we pay through the nose for them too...

The Effect of Drug Fee Schedules and Other Factors on Workers’ Comp Prescription Drug Costs

By Roger Rabb, J.D., Special Correspondent for the LexisNexis Workers’ Compensation eNewsletter NCCI studies have shown that establishing a fee schedule for physician services can help keep down costs in workers’ compensation claims, and in “ The Impact of Workers Compensation Drug...

Physicians and Drug Companies Strike Back at Attempts to Curb Drug Costs

Are reform efforts aimed at controlling the costs of physician-dispensed drugs having the desired effect? It appears not, at least in California, Florida, Pennsylvania, Illinois, and Tennessee. In recent years, at least 20 states have made legislative or regulatory changes attempting to control the...